Drug consumption rooms (DCRs) as a setting to address hepatitis C – findings from an international online survey
Tóm tắt
Prevalence of Hepatitis C Virus (HCV) among people who inject drugs (PWID) is high. Risky injecting behaviours have been found to decrease in drug consumption rooms (DCRs) and supervised injecting facilities (SIFs), yet HCV prevention and treatment in these settings have not been extensively explored. To determine the range and scope of HCV prevention and treatment options in these services, we assessed DCR/SIF operational features, their clients’ characteristics and the HCV-related services they provide. A comprehensive online survey was sent to the managers of the 91 DCRs/SIFs that were operating globally as of September 2016. A descriptive cross-country analysis of the main DCR/SIF characteristics was conducted and bivariate logistic models were used to assess factors associated with enhanced HCV service provision. Forty-nine valid responses were retrieved from DCRs/SIFs in all countries where they were established at the time of the survey (Australia, Canada, Denmark, France, Germany, Luxembourg, Netherlands, Norway, Spain and Switzerland). Internationally, the operational capacities of DCRs/SIFs varied in terms of funding, location, size and staffing, but their clients all shared common features of vulnerability and marginalisation. Estimated HCV prevalence rates were around 60%. Among a range of health and social services and referrals to other programs, most DCRs/SIFs provided HCV testing onsite (65%) and/or offered liver monitoring or disease management (54%). HCV treatment onsite was offered or was planned to be offered by 21% of DCRs/SIFs. HCV testing onsite was associated with provision of other services addressing blood-borne diseases and HCV treatment was linked to the provision of OST. HCV disease management was associated with employing a nurse at a DCR/SIF and HCV treatment was associated with employing a medical doctor. DCRs/SIFs offer easy-to-access HCV-related services for PWID. The availability of onsite medical professionals and provision of support and education to non-medical staff are key to enhanced provision of HCV-related services in DCRs/SIFs. Funding and support for HCV treatment at the community level, via low-threshold services such as DCRs/SIFs, are worthy of action.
Tài liệu tham khảo
citation_title=Supervised consumption services: operational guidance; citation_inbook_title=Edited by the steering Committee for the Supervised Consumption Services Guidelines; citation_publication_date=2018; citation_id=CR1; citation_publisher=British Columbia Centre on Substance Use, Ministry of Health
citation_title=Drug consumption rooms: an overview of provision and evidence; citation_inbook_title=Perspectives on drugs; citation_publication_date=2016; citation_id=CR2; citation_publisher=European Monitoring Centre for Drugs and Drug Addiction
Hedrich D, Hartnoll R. Harm reduction interventions. Textbook of Addiction Treatment: International Perspectives. 2015:1291–313.
citation_title=Drug consumption facilities in Europe and beyond; citation_inbook_title=EMCDDA Scientific Monograph Series No 10- Harm Reduction: Evidence, Impacts and Challenges; citation_publication_date=2010; citation_id=CR4; citation_author=D Hedrich; citation_author=T Kerr; citation_author=F Dubois-Arber; citation_publisher=The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
citation_journal_title=Current HIV/AIDS Reports; citation_title=The role of safer injection facilities in the response to HIV/AIDS among injection drug users; citation_author=T Kerr, J Kimber, K DeBeck, E Wood; citation_volume=4; citation_issue=4; citation_publication_date=2007; citation_pages=158-164; citation_doi=10.1007/s11904-007-0023-8; citation_id=CR5
citation_journal_title=Drug and Alcohol Review; citation_title=Drug consumption facilities: an update since 2000; citation_author=J Kimber, K Dolan, I Van Beek, D Hedrich, H Zurhold; citation_volume=22; citation_issue=2; citation_publication_date=2003; citation_pages=227-233; citation_doi=10.1080/095952301000116951; citation_id=CR6
citation_title=Harm reduction among injecting drug users-evidence of effectiveness; citation_inbook_title=Harm Reduction: evidence, impacts and challenges; citation_publication_date=2010; citation_pages=115-163; citation_id=CR7; citation_author=J Kimber; citation_author=N Palmateer; citation_author=S Hutchinson; citation_author=M Hickman; citation_author=D Goldberg; citation_author=T Rhodes; citation_publisher=EMCDDA
citation_journal_title=Addiction; citation_title=Emerging role of supervised injecting facilities in human immunodeficiency virus prevention; citation_author=MJ Milloy, E Wood; citation_volume=104; citation_issue=4; citation_publication_date=2009; citation_pages=620-621; citation_doi=10.1111/j.1360-0443.2009.02541.x; citation_id=CR8
citation_journal_title=Graduate Annual; citation_title=Out of the alley: lessons from safe injecting facilities (SIF); citation_author=D Monico; citation_volume=3; citation_issue=1; citation_publication_date=2015; citation_pages=12; citation_id=CR9
citation_journal_title=Drug Alcohol Depend; citation_title=Supervised injection services: what has been demonstrated? A systematic literature review; citation_author=C Potier, V Laprévote, F Dubois-Arber, O Cottencin, B Rolland; citation_volume=145; citation_publication_date=2014; citation_pages=48-68; citation_doi=10.1016/j.drugalcdep.2014.10.012; citation_id=CR10
citation_journal_title=Drug Alcohol Depend; citation_title=Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States; citation_author=S Semaan, P Fleming, C Worrell, H Stolp, B Baack, M Miller; citation_volume=118; citation_publication_date=2011; citation_pages=11; citation_doi=10.1016/j.drugalcdep.2011.03.006; citation_id=CR11
citation_journal_title=Am J Prev Med; citation_title=Do supervised injecting facilities attract higher-risk injection drug users?; citation_author=E Wood, MW Tyndall, K Li, E Lloyd-Smith, W Small, JSG Montaner, T Kerr; citation_volume=29; citation_issue=2; citation_publication_date=2005; citation_pages=126-130; citation_doi=10.1016/j.amepre.2005.04.011; citation_id=CR12
citation_journal_title=Crit Public Health; citation_title=The Sydney medically supervised injecting Centre: reducing harm associated with heroin overdose; citation_author=I van Beek, J Kimber, A Dakin, S Gilmour; citation_volume=14; citation_issue=4; citation_publication_date=2004; citation_pages=391-406; citation_doi=10.1080/09581590400027528; citation_id=CR13
citation_journal_title=Addiction; citation_title=Use of supervised injection facilities and injection risk behaviours among young drug injectors; citation_author=MJ Bravo, L Royuela, L De la Fuente, MT Brugal, G Barrio, A Domingo-Salvany; citation_volume=104; citation_issue=4; citation_publication_date=2009; citation_pages=614-619; citation_doi=10.1111/j.1360-0443.2008.02474.x; citation_id=CR14
citation_journal_title=Am J Public Health; citation_title=Service uptake and characteristics of injection drug users utilizing north Americas first medically supervised safer injecting facility; citation_author=E Wood, MW Tyndall, Z Qui, R Zhang, JSG Montaner, T Kerr; citation_volume=96; citation_issue=5; citation_publication_date=2006; citation_pages=770-773; citation_doi=10.2105/AJPH.2004.057828; citation_id=CR15
citation_journal_title=J Subst Abus Treat; citation_title=Undiagnosed HIV and hepatitis C infection in people who inject drugs: from new evidence to better practice; citation_author=O Parés-Badell, A Espelt, C Folch, X Majó, V González, J Casabona, MT Brugal; citation_volume=77; citation_publication_date=2017; citation_pages=13-20; citation_doi=10.1016/j.jsat.2017.03.003; citation_id=CR16
KPMG. Further evaluation of the Medically Supervised Injecting Centre during its extended trial period (2007-2011): Final report. Sydney: KPMG. p. 2010.
citation_title=Final report of the evaluation of the Sydney medically supervised injecting Centre; citation_publication_date=2003; citation_id=CR18; citation_publisher=Authors
citation_journal_title=Aust N Z J Public Health; citation_title=High HIV testing and low HIV prevalence among injecting drug users attending the Sydney medically supervised injecting Centre; citation_author=AM Salmon, I van Beek, J Amin, A Grulich, L Maher; citation_volume=33; citation_issue=3; citation_publication_date=2009; citation_pages=280-283; citation_doi=10.1111/j.1753-6405.2009.00389.x; citation_id=CR19
citation_journal_title=International Journal of Drug Policy; citation_title=A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility; citation_author=MA Andresen, N Boyd; citation_volume=21; citation_issue=1; citation_publication_date=2010; citation_pages=70-76; citation_doi=10.1016/j.drugpo.2009.03.004; citation_id=CR20
citation_journal_title=Can Med Assoc J; citation_title=The cost-effectiveness of Vancouver's supervised injection facility; citation_author=AM Bayoumi, GS Zaric; citation_volume=179; citation_issue=11; citation_publication_date=2008; citation_pages=1143-1151; citation_doi=10.1503/cmaj.080808; citation_id=CR21
citation_journal_title=Addiction; citation_title=Is Vancouver Canada's supervised injection facility cost-saving?; citation_author=SD Pinkerton; citation_volume=105; citation_issue=8; citation_publication_date=2010; citation_pages=1429-1436; citation_doi=10.1111/j.1360-0443.2010.02977.x; citation_id=CR22
citation_journal_title=Journal of Public Health; citation_title=Changes in injecting practices associated with the use of a medically supervised safer injection facility; citation_author=J-A Stoltz, E Wood, W Small, K Li, M Tyndall, J Montaner, T Kerr; citation_volume=29; citation_issue=1; citation_publication_date=2007; citation_pages=35-39; citation_doi=10.1093/pubmed/fdl090; citation_id=CR23
Wood E, Tyndall MW, Stoltz J-A, Small W, Lloyd-Smith E, Zhang R, Montaner JSG, Kerr T. Factors Associated with Syringe Sharing Among Users of a Medically Supervised Safer Injecting Facility. American Jounral of Infectious Diseases. 2005:1(1).
citation_journal_title=Harm Reduct J; citation_title=Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen Denmark; citation_author=EN Kinnard, CJ Howe, T Kerr, VS Hass, BD Marshall; citation_volume=11; citation_issue=1; citation_publication_date=2014; citation_pages=1; citation_doi=10.1186/1477-7517-11-29; citation_id=CR25
citation_journal_title=J Drug Issues; citation_title=Drug consumption rooms in Hamburg, Germany: evaluation of the effects on harm reduction and the reduction of public nuisance; citation_author=H Zurhold, P Degkwitz, U Verthein, C Haasen; citation_volume=33; citation_issue=3; citation_publication_date=2003; citation_pages=663-688; citation_doi=10.1177/002204260303300308; citation_id=CR26
citation_journal_title=Clin Infect Dis; citation_title=Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis; citation_author=RB Dimova, M Zeremski, IM Jacobson, H Hagan, DC Des Jarlais, AH Talal; citation_volume=56; citation_issue=6; citation_publication_date=2013; citation_pages=806-816; citation_doi=10.1093/cid/cis1007; citation_id=CR27
citation_journal_title=Clin Infect Dis; citation_title=Hepatitis C virus reinfection following treatment among people who use drugs; citation_author=BP Grady, J Schinkel, XV Thomas, O Dalgard; citation_volume=57; citation_issue=suppl 2; citation_publication_date=2013; citation_pages=S105-S110; citation_doi=10.1093/cid/cit301; citation_id=CR28
citation_journal_title=Hepatology; citation_title=Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations; citation_author=NK Martin, P Vickerman, A Miners, GR Foster, SJ Hutchinson, DJ Goldberg, M Hickman; citation_volume=55; citation_issue=1; citation_publication_date=2012; citation_pages=49-57; citation_doi=10.1002/hep.24656; citation_id=CR29
citation_journal_title=J Gastroenterol Hepatol; citation_title=Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia; citation_author=AJ Visconti, JS Doyle, A Weir, AM Shiell, ME Hellard; citation_volume=28; citation_issue=4; citation_publication_date=2013; citation_pages=707-716; citation_doi=10.1111/jgh.12041; citation_id=CR30
citation_journal_title=Gastoenterology & Hepatology; citation_title=Direct-acting antiviral agents for HCV infection affecting people who inject drugs; citation_author=J Grebely, B Hajarizadeh, GJ Dore; citation_volume=1; citation_publication_date=2017; citation_pages=1-11; citation_id=CR31
citation_journal_title=Liver Int; citation_title=Barriers to hepatitis C treatment; citation_author=CE McGowan, MW Fried; citation_volume=32; citation_issue=s1; citation_publication_date=2012; citation_pages=151-156; citation_doi=10.1111/j.1478-3231.2011.02706.x; citation_id=CR32
citation_journal_title=Hepatology, Medicine and Policy; citation_title=Urgent action to fight hepatitis C in people who inject drugs in Europe; citation_author=JF Dillon, JV Lazarus, HA Razavi; citation_volume=1; citation_issue=2; citation_publication_date=2016; citation_pages=1-10; citation_id=CR33
citation_journal_title=European Addiction Research; citation_title=Typology of injection profiles of clients of a supervised drug consumption facility in Geneva Switzerland; citation_author=F Dubois-Arber, F Benninghoff, A Jeannin; citation_volume=14; citation_issue=1; citation_publication_date=2008; citation_pages=1-10; citation_doi=10.1159/000110405; citation_id=CR34
citation_title=Organisational overview of drug consumption rooms in Europe; citation_publication_date=2014; citation_id=CR35; citation_author=S Woods; citation_publisher=European Harm Reduction Network – Regenboog Groep
Kimber JO, Dolan K, Wodak A. Survey of drug consumption rooms: service delivery and perceived public health and amenity impact. Drug and Alcohol Review. 2005;24(1):21–4.
citation_journal_title=BMC Public Health; citation_title=Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals; citation_author=ZC Rich, C Chu, J Mao, K Zhou, W Cai, Q Ma, P Volberding, JD Tucker; citation_volume=16; citation_issue=1; citation_publication_date=2016; citation_pages=994; citation_doi=10.1186/s12889-016-3671-z; citation_id=CR37
citation_journal_title=Hepatology, Medicine and Policy; citation_title=Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany; citation_author=S Nielsen, M Gassowski, B Wenz, N Bannert, C-T Bock, C Kücherer, RS Ross, V Bremer, U Marcus, R Zimmermann; citation_volume=1; citation_issue=1; citation_publication_date=2016; citation_pages=8; citation_doi=10.1186/s41124-016-0016-6; citation_id=CR38
citation_journal_title=International Journal of Drug Policy; citation_title=Recommendations for the management of hepatitis C virus infection among people who inject drugs; citation_author=J Grebely, G Robaeys, P Bruggmann, A Aghemo, M Backmund, J Bruneau, J Byrne, O Dalgard, JJ Feld, M Hellard; citation_volume=26; citation_issue=10; citation_publication_date=2015; citation_pages=1028-1038; citation_doi=10.1016/j.drugpo.2015.07.005; citation_id=CR39
citation_journal_title=Clinical Infectious Diseases; citation_title=Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy; citation_author=NK Martin, M Hickman, SJ Hutchinson, DJ Goldberg, P Vickerman; citation_volume=57; citation_issue=suppl_2; citation_publication_date=2013; citation_pages=S39-S45; citation_doi=10.1093/cid/cit296; citation_id=CR40
citation_journal_title=PLoS One; citation_title=Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention; citation_author=L Wiessing, M Ferri, B Grady, M Kantzanou, I Sperle, KJ Cullen, A Hatzakis, M Prins, P Vickerman, JV Lazarus; citation_volume=9; citation_issue=7; citation_publication_date=2014; citation_doi=10.1371/journal.pone.0103345; citation_id=CR41
citation_journal_title=J Hepatol; citation_title=Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam; citation_author=TJ van de Laar, R Molenkamp, C van den Berg, J Schinkel, MG Beld, M Prins, RA Coutinho, SM Bruisten; citation_volume=51; citation_issue=4; citation_publication_date=2009; citation_pages=667-674; citation_doi=10.1016/j.jhep.2009.05.027; citation_id=CR42
citation_journal_title=J Epidemiol Community Health; citation_title=Large decline in injecting drug use in Amsterdam, 1986–1998: explanatory mechanisms and determinants of injecting transitions; citation_author=E Van Ameijden, R Coutinho; citation_volume=55; citation_issue=5; citation_publication_date=2001; citation_pages=356-363; citation_doi=10.1136/jech.55.5.356; citation_id=CR43
citation_journal_title=J Med Virol; citation_title=Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands; citation_author=TJ van de Laar, MW Langendam, SM Bruisten, EA Welp, I Verhaest, EJ van Ameijden, RA Coutinho, M Prins; citation_volume=77; citation_issue=4; citation_publication_date=2005; citation_pages=509-518; citation_doi=10.1002/jmv.20486; citation_id=CR44
citation_journal_title=Drug and Alcohol Review; citation_title=Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia; citation_author=K Dolan, J Kimber, C Fry, D McDonald, J Fitzgerald, F Trautmann; citation_volume=19; citation_issue=3; citation_publication_date=2000; citation_pages=337-346; citation_doi=10.1080/713659379; citation_id=CR45
citation_title=Supervised consumption sites: status of applications; citation_publication_date=2018; citation_id=CR46; citation_publisher=Government of Canada
Williams S: Opinion: Safe injection sites a small step but big milestone in saving lives. In: Edmonton Journal. vol. 25th October, 2017. Edmonton; 2017.
https://edmontonjournal.com/opinion/columnists/opinion-safe-injection-sites-a-small-step-but-big-milestone-in-saving-lives
, Retrieved on 30th July, 2018.
citation_journal_title=Int J Drug Policy; citation_title=Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: findings from the Queensland injectors’ health network; citation_author=L Morris, A Smirnov, A Kvassay, E Leslie, R Kavanagh, N Alexander, G Davey, O Williams, C Gilks, J Najman; citation_volume=47; citation_publication_date=2017; citation_pages=216-20; citation_doi=10.1016/j.drugpo.2017.05.056; citation_id=CR48
citation_journal_title=BMJ Hepatology, Medicine and Policy; citation_title=Edito-in-Chief’s welcome to Hepatology, medicine and policy; citation_author=JV Lazarus; citation_volume=1; citation_issue=1; citation_publication_date=2016; citation_pages=1-3; citation_doi=10.1186/s41124-016-0005-9; citation_id=CR49
citation_journal_title=PLoS Med; citation_title=Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis; citation_author=S Iyengar, K Tay-Teo, S Vogler, P Beyer, S Wiktor, K de Joncheere, S Hill; citation_volume=13; citation_issue=5; citation_publication_date=2016; citation_doi=10.1371/journal.pmed.1002032; citation_id=CR50
citation_journal_title=Hepatology, Medicine and Policy; citation_title=Innovative sources for funding of viral hepatitis prevention and treatment in low-and middle-income countries: a roundtable meeting report; citation_author=D FitzSimons, G Hendrickx, J Hallauer, H Larson, D Lavanchy, I Lodewyckx, D Shouval, J Ward, P Van Damme; citation_volume=1; citation_issue=1; citation_publication_date=2016; citation_pages=16; citation_doi=10.1186/s41124-016-0022-8; citation_id=CR51